Tryforos, Margaret

Tryforos, Margaret was paid $652K by Medicaid between Apr 2018 and Apr 2024, across 16 billing codes. Its largest line is 99211, Office or other outpatient visit for the evaluation and management of an established patient, minimal severity — 88% of everything it billed.

33Billing provider infoTRYFOROS, MARGARET
PAWTUCKET, RI 02860

33aNPI1295710879assigned 12/07/2005

33bProvider typeFamily Medicine Physician

28Total paid$652K

24GClaims4,795

24DCodes billed16

24AFirst – last monthApr 2018 – Apr 2024

Compared with peers

Next to other Family Medicine Physician providers in Rhode Island

Rank by total paid#11 of 220

Median peer was paid$33K

This provider vs. median20×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	638	$81K
2019	611	$97K
2020	761	$92K
2021	1,091	$128K
2022	878	$118K
2023	567	$99K
2024incomplete	249	$38K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	88%	3,366	3,126	$576K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	3.2%	380	360	$21K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	2.9%	468	411	$19K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	1.3%	105	101	$8K
83036	Hemoglobin; glycosylated (A1C)	<1%	104	101	$6K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	60	59	$5K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	79	72	$4K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	43	42	$3K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	31	30	$2K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	13	13	$2K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	36	26	$2K
80048	Basic metabolic panel (calcium, ionized)	<1%	43	40	$2K

4 more codes

80061	Lipid panel	<1%	12	$729.12
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	30	$687.37
84443	Thyroid stimulating hormone (TSH)	<1%	12	$669.28
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	13	$379.28

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.